Prevalence of cytopenia(s) and somatic variants in patients with <i>DDX41</i> mutant germline predisposition syndromeYael Kusne, Mrinal M. Patnaik, Alejandro Ferrer et al.|British Journal of Haematology|2025Cited by 10
Prevalence and Clinical Features of Non-Myeloid Neoplasms in Patients with <i>DDX41</i> Mutant Germline Predisposition SyndromeYael Kusne, Mrinal M. Patnaik, Talha Badar et al.|Blood|2024Cited by 2
Clinical Characteristics of Myeloproliferative Neoplasms in Patients with <i>DDX41</i>MT Germline Predisposition SyndromeYael Kusne, Mrinal M. Patnaik, Talha Badar et al.|Blood|2024Cited by 1
Decoding DDX41: Clinical impact of germline and somatic mutations in 77 high-risk myeloid neoplasm patientsTalha Badar, Mrinal M. Patnaik, Mahesh Kumar et al.|Blood|2025Cited by 1
Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired BM failure syndromesYael Kusne, Mrinal M. Patnaik, Talha Badar et al.|Leukemia Research|2024Cited by 1